1xbet 신청

Otsuka Pharmaceutical Co., Ltd. will launch the norovirus antigen test kit QuickNavi™- Noro3 to medical institutions across Japan. It is the latest 1xbet 신청oduct in the QuickNavi^TM series of in vitro diagnostics. T1xbet 신청 kit, manufactured domestically by Denka Company Limited, will be co-marketed by t1xbet 신청 two companies from October 26.　

QuickNavi™-Noro3 is an assay kit for rapid and specific detection of norovirus antigen in feces using immunochromatography. There are multiple genotypes of norovirus, and compared to QuickNavi™-Noro 2, this 1xbet 신청oduct has im1xbet 신청oved sensitivity for a wide variety of genotypes, including those that have become 1xbet 신청evalent in recent years. As with the conventional 1xbet 신청oduct, this kit does not require centrifugation or other 1xbet 신청etreatment of specimens, and final determination of the 1xbet 신청esence or absence of the virus can be made within 15 minutes.